Betamethasone valerate foam for treatment of nonscalp psoriasis

Journal of Cutaneous Medicine and Surgery

Volumn 5, Issue 4, 2001, Pages 303-307

  Stein, Linda F ^a   Sherr, Amelia ^b   Solodkina, Galina ^b   Gottlieb, Alice B ^b   Chaudhari, Umesh ^b  

^a HENRY FORD HOSPITAL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; LUXIQ; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOAM; HUMAN; MALE; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE 17-VALERATE; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PLACEBOS; PSORIASIS; TIME FACTORS;

EID: 0034853330     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-001-0006-0     Document Type: Article

References (10)

1. The physical, psychological and social impact of psoriasis
2. Psoriasis causes as much disability as other major medical diseases
3. Health related quality of life in psoriasis: A biopsychosocial model and measures
4. Clearance is not a realistic expectation of psoriasis treatment
5. Patients with psoriasis their compliance with medication
6. Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy
7. Principles of topical therapy
8. New topical treatments change the pattern of treatment of psoriasis: Dermatologists remain the primary providers of this care
9. Topical application of calcipotriene and corticosteroids: Combination regimens
10. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis